Relationship of age, atherosclerosis and angiographic stenosis using artificial intelligence

Abstract

ObjectiveThe study evaluates the relationship of coronary stenosis, atherosclerotic plaque characteristics (APCs) and age using artificial intelligence enabled quantitative coronary computed tomographic angiography (AI-QCT).MethodsThis is a post-hoc analysis of data from 303 subjects enrolled in the CREDENCE (Computed TomogRaphic Evaluation of Atherosclerotic Determinants of Myocardial IsChEmia) trial who were referred for invasive coronary angiography and subsequently underwent coronary computed tomographic angiography (CCTA). In this study, a blinded core laboratory analysing quantitative coronary angiography images classified lesions as obstructive (≥50%) or non-obstructive (<50%) while AI software quantified APCs including plaque volume (PV), low-density non-calcified plaque (LD-NCP), non-calcified plaque (NCP), calcified plaque (CP), lesion length on a per-patient and per-lesion basis based on CCTA imaging. Plaque measurements were normalised for vessel volume and reported as % percent atheroma volume (%PAV) for all relevant plaque components. Data were subsequently stratified by age <65 and ≥65 years.ResultsThe cohort was 64.4±10.2 years and 29% women. Overall, patients >65 had more PV and CP than patients <65. On a lesion level, patients >65 had more CP than younger patients in both obstructive (29.2 mm3 vs 48.2 mm3; p<0.04) and non-obstructive lesions (22.1 mm3 vs 49.4 mm3; p<0.004) while younger patients had more %PAV (LD-NCP) (1.5% vs 0.7%; p<0.038). Younger patients had more PV, LD-NCP, NCP and lesion lengths in obstructive compared with non-obstructive lesions. There were no differences observed between lesion types in older patients.ConclusionAI-QCT identifies a unique APC signature that differs by age and degree of stenosis and provides a foundation for AI-guided age-based approaches to atherosclerosis identification, prevention and treatment.

Diabetes, Atherosclerosis, and Stenosis by AI

“…Here the data show that patients with diabetes have similar plaque composition in obstructive and nonobstructive lesions. This aligns with the findings of a prior study on age-based plaque composition that showed that the plaque profile becomes less distinct with more varied APC composition in older patients with longstanding disease ( 37 ). It also suggests that additional components other than distinct APCs and stenosis may be responsible for ischemia-inducing lesions in this population.…”

Impact of atherosclerosis imaging-quantitative computed tomography on diagnostic certainty, downstream testing, coronary revascularization, and medical therapy: the CERTAIN study

“… 9 This FDA-cleared software service utilizes a series of validated convolutional neural networks for image quality assessment, coronary segmentation and labelling, lumen wall evaluation, vessel contour determination, and plaque characterization. Prior validation of AI-QCT has been reported in multi-centre trials using expert consensus, quantitative coronary angiography, and fractional flow reserve (FFR) as previously published, 9 , 10 , 12 as well as intravascular ultrasound. 15 The algorithm first produces a centreline, lumen, and outer vessel wall contouring for every phase available and subsequently selects the optimal series for analysis.…”

Evolutionary trends and innovations in cardiovascular intervention

“…AI offers an innovative approach to risk assessment, early disease detection, and guidance in formulating personalized intervention strategies. AI-driven algorithms, capable of analyzing extensive datasets, become indispensable tools for predicting patient outcomes and assisting healthcare professionals in real-time decision-making during cardiovascular interventions ( 20 ).…”